Association of 2024–2025 Covid-19 Vaccine with Covid-19 Outcomes in U.S. Veterans

In this national cohort of U.S. veterans, the receipt of the 2024-2025 Covid-19 vaccine was associated with decreased risks of severe clinical outcomes. (Funded by the Department of Veterans Affairs.).

Authors

Institutions

Publication Details

Journal
New England Journal of Medicine
Published
2025-10-08
DOI
https://doi.org/10.1056/nejmoa2510226
Citations
19
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
26.53
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Association of 2024–2025 Covid-19 Vaccine with Covid-19 Outcomes in U.S. Veterans

Miao Cai, Yan Xie, Ziyad Al‐Aly
19 citations
New England Journal of Medicine
SARS-CoV-2 and COVID-19 Research
26.53
article

Association of 2024–2025 Covid-19 Vaccine with Covid-19 Outcomes in U.S. Veterans

Miao Cai, Yan Xie, Ziyad Al‐Aly
article en
19 citations

Abstract

In this national cohort of U.S. veterans, the receipt of the 2024-2025 Covid-19 vaccine was associated with decreased risks of severe clinical outcomes. (Funded by the Department of Veterans Affairs.).

New England Journal of MedicineVol. 393(16)
Washington University in St. Louis (US), VA St. Louis Health Care System (US), Saint Louis University (US)
Openalex Percentile: Top 0%
SARS-CoV-2 and COVID-19 Research
26.53
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.